Peter Lamas Products at Duane Reade flagship store
NEW YORK The natural hair care line by makeup and beauty expert Peter Lamas, founder of Peter Lamas Products, made its way to Duane Reade in the spring and was spotted on shelf at the recently opened Duane Reade flagship store in Union Square.
Lamas has more than 30 years of experience in the beauty industry, defining the looks of Hollywood’s hottest stars, such as Audrey Hepburn, Grace Kelly and Elizabeth Taylor.
Periscope introduces Flip Cover+Lights
RIDGEWOOD, N.J. Periscope has introduced an integrated reading light and deluxe cover for e-readers.
Periscope’s Flip Cover+Lights is available in two versions — one that’s compatible with both the Amazon Kindle 2 (6-inch screen) and Barnes & Noble Nook e-readers and a second larger version that is compatible with the Amazon Kindle DX e-reader.
The new Flip Cover+Lights are available at the following suggested retail prices: $49.95 for the Kindle 2/Nook version and $59.95 for the larger Kindle DX version.
“As the market for e-readers grows and expands at an explosive rate, so too does the demand for e-reader covers and reading lights,” said Periscope president Eric Fisherman. “Covers and lights are essential components of the e-reader package and neither is included with a basic e-reader purchase. What’s more, all current e-readers are standardized on a screen technology that is not back lit, which makes the purchase of a reading light mandatory if the product is to be enjoyed in a low light environment.”
Pfizer’s Xyntha-administering syringe gets FDA approval
NEW YORK The Food and Drug Administration has approved a prefilled dual-chamber syringe made by Pfizer for treating hemophilia, Pfizer said.
The FDA approved the syringe for administering the drug Xyntha (antihemophilic factor [recombinant]) for hemophilia A. The drug is used to prevent and control bleeding episodes in patients.
“The approval of the pre-filled dual-chamber syringe is an important milestone for hemophilia patients due to its innovative, convenient reconstitution system that eliminates the transfer step,” Pfizer VP marketing for specialty biologics Emil Andrusko said.